HealthStream (HSTM) Getting Somewhat Favorable News Coverage, Accern Reports

Media headlines about HealthStream (NASDAQ:HSTM) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. HealthStream earned a news impact score of 0.12 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 46.7622654139083 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the news headlines that may have impacted Accern’s analysis:

Several equities analysts recently commented on the stock. Zacks Investment Research cut shares of HealthStream from a “hold” rating to a “sell” rating in a research note on Wednesday, July 26th. Robert W. Baird decreased their price objective on shares of HealthStream from $30.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday. Needham & Company LLC reissued a “hold” rating and set a $26.00 price objective on shares of HealthStream in a report on Tuesday. First Analysis raised shares of HealthStream from an “underweight” rating to an “equal weight” rating and set a $19.00 target price on the stock in a research note on Wednesday, July 26th. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $25.00 target price on shares of HealthStream in a research note on Monday. One analyst has rated the stock with a sell rating, four have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $25.14.

Shares of HealthStream (NASDAQ:HSTM) traded down 0.43% during trading on Friday, hitting $23.05. 61,812 shares of the stock traded hands. The company has a 50-day moving average of $23.64 and a 200-day moving average of $25.46. The firm has a market cap of $734.97 million, a P/E ratio of 165.83 and a beta of 0.98. HealthStream has a 52 week low of $20.60 and a 52 week high of $31.53.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. The company had revenue of $63.60 million during the quarter, compared to analysts’ expectations of $62.48 million. HealthStream had a return on equity of 2.46% and a net margin of 2.36%. HealthStream’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.04 earnings per share. On average, analysts forecast that HealthStream will post $0.23 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at

HealthStream Company Profile

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Insider Buying and Selling by Quarter for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream Inc. and related companies with's FREE daily email newsletter.

Leave a Reply